Latest Insider Transactions at Hanover Insurance Group, Inc. (THG)
This section provides a real-time view of insider transactions for Hanover Insurance Group, Inc. (THG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HANOVER INSURANCE GROUP, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HANOVER INSURANCE GROUP, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 17
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
39,575
-33.64%
|
$5,857,100
$148.76 P/Share
|
May 17
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
47,510
+28.77%
|
$4,941,040
$104.11 P/Share
|
May 10
2022
|
Cynthia Egan Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+8.34%
|
-
|
May 10
2022
|
Harriett Tee Taggart Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+6.09%
|
-
|
May 10
2022
|
Joseph R Ramrath Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+3.09%
|
-
|
May 10
2022
|
Kathy S Lane Director |
BUY
Grant, award, or other acquisition
|
Indirect |
946
+21.7%
|
-
|
May 10
2022
|
Wendell J Knox Director |
BUY
Grant, award, or other acquisition
|
Indirect |
946
+21.7%
|
-
|
May 10
2022
|
Martin P Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+16.34%
|
-
|
May 10
2022
|
J Paul Condrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+30.39%
|
-
|
May 10
2022
|
Jane D Carlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+50.0%
|
-
|
May 10
2022
|
Theodore H Bunting Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+24.95%
|
-
|
May 10
2022
|
Kevin Bradicich Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+13.8%
|
-
|
Apr 21
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
922
-1.22%
|
$142,910
$155.24 P/Share
|
Apr 21
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
922
+1.2%
|
$36,880
$40.01 P/Share
|
Mar 29
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
2,725
-3.51%
|
$408,750
$150.47 P/Share
|
Mar 29
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,725
+3.39%
|
$109,000
$40.01 P/Share
|
Mar 28
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
4,533
-5.71%
|
$679,950
$150.09 P/Share
|
Mar 28
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,533
+5.4%
|
$181,320
$40.01 P/Share
|
Mar 25
2022
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.12%
|
-
|
Mar 25
2022
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.49%
|
-
|
Mar 25
2022
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.08%
|
-
|
Mar 25
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.24%
|
-
|
Mar 25
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
49
+0.07%
|
-
|
Mar 25
2022
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
Mar 25
2022
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.42%
|
-
|
Mar 25
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.07%
|
-
|
Mar 25
2022
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.14%
|
-
|
Mar 18
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
78,161
-38.0%
|
$11,333,345
$145.25 P/Share
|
Mar 18
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
105,022
+33.86%
|
$8,191,716
$78.19 P/Share
|
Mar 17
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
7,258
-4.48%
|
$1,052,410
$145.93 P/Share
|
Mar 17
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,258
+8.13%
|
$290,320
$40.01 P/Share
|
Mar 08
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Open market or private sale
|
Direct |
649
-13.45%
|
$90,211
$139.74 P/Share
|
Mar 07
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-4.91%
|
$34,611
$139.52 P/Share
|
Mar 07
2022
|
Mark Joseph Welzenbach Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,077
-4.57%
|
$149,703
$139.52 P/Share
|
Mar 07
2022
|
Bryan J Salvatore Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-6.65%
|
$168,607
$139.52 P/Share
|
Mar 07
2022
|
John C Roche President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,565
-9.19%
|
$1,051,535
$139.52 P/Share
|
Mar 07
2022
|
Willard T Lee Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-9.49%
|
$46,148
$139.52 P/Share
|
Mar 07
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,816
-10.03%
|
$669,424
$139.52 P/Share
|
Mar 07
2022
|
Richard W Lavey Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-6.21%
|
$260,347
$139.52 P/Share
|
Mar 02
2022
|
Richard W Lavey Executive Vice President |
SELL
Open market or private sale
|
Direct |
9,253
-13.17%
|
$1,304,673
$141.1 P/Share
|
Mar 02
2022
|
Richard W Lavey Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,253
+11.57%
|
$555,180
$60.38 P/Share
|
Feb 28
2022
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
628
+15.92%
|
-
|
Feb 28
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,504
+4.93%
|
-
|
Feb 28
2022
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
672
+22.24%
|
-
|
Feb 28
2022
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
4,302
+7.84%
|
-
|
Feb 28
2022
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
5,002
+5.5%
|
-
|
Feb 28
2022
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,647
+8.34%
|
-
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
955
+6.07%
|
-
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
SELL
Open market or private sale
|
Direct |
3,889
-23.17%
|
$544,460
$140.0 P/Share
|
Feb 28
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,889
+18.51%
|
$455,013
$117.04 P/Share
|